AQB
AQB
NASDAQ · Biotechnology

Aquabounty Technologies

$1.09
-0.01 (-0.91%)
As of Jun 29, 10:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.37M
Net Income
-202,299,699
Gross Margin
-518.0%
Profit Margin
-1,132.4%
Rev Growth
+166.9%
D/E Ratio
0.21
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -518.0% 56.6% 56.6% 56.6%
Operating Margin -566.2% 16.8% 16.3% 16.4%
Profit Margin -1,132.4% 13.8% 16.5% 14.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.37M 557.3K 516.3K 473.8K
Gross Profit -17,480,812 315.4K 292.2K 268.1K
Operating Income -19,106,330 93.8K 84.3K 77.8K
Net Income -202,299,699 76.7K 85.4K 67.5K
Gross Margin -518.0% 56.6% 56.6% 56.6%
Operating Margin -566.2% 16.8% 16.3% 16.4%
Profit Margin -1,132.4% 13.8% 16.5% 14.2%
Rev Growth +166.9% +2.4% +15.9% +18.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 491.6K 1.31M 1.47M 1.37M
Total Equity 2.39M 2.49M 2.28M 2.29M
D/E Ratio 0.21 0.52 0.64 0.60
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -149,478,834 122.1K 108.8K 88.6K
Free Cash Flow 55.8K 59.0K 42.6K